Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

A(1-7) treatment reduces symptoms of lupus in mice.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

OXTR agonists may promote hair growth and be effective for treating hair loss.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

BTA safely and effectively treats hair loss, and works better with FNS.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Minoxidil can reduce functions related to androgen receptors.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

MPA increases cancer spread by boosting Eph A2 activity.

Tamsulosin increases the risk of floppy iris during eye surgery.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Muscarinic acetylcholine receptors help regulate and promote hair growth.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Finasteride effectively prevents hair loss and promotes hair growth in men with androgenetic alopecia.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Mutations in certain receptors can cause diseases and offer new treatment options.

Oral minoxidil may improve hair loss in men and women, but has some side effects.